» Articles » PMID: 25009374

Challenges in Transplantation for Alcoholic Liver Disease

Overview
Specialty Gastroenterology
Date 2014 Jul 11
PMID 25009374
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Transplantation for the treatment of alcoholic cirrhosis is more controversially discussed than it is for any other indication. The crucial aspect in this setting is abstinence before and after liver transplantation. We established pre-transplant selection criteria for potential transplant candidates. Provided that the underlying disease can be treated, there is no reason to withhold liver transplantation in a patient suffering from alcoholic cirrhosis. Evaluation of the patient by a multidisciplinary team, including an addiction specialist, is considered to be the gold standard. However, several centers demand a specified period of abstinence - usually 6 mo- irrespective of the specialist's assessment. The 6-mo rule is viewed critically because liver transplantation was found to clearly benefit selected patients with acute alcoholic hepatitis; the benefit was similar to that achieved for other acute indications. However, the discussion may well be an academic one because the waiting time for liver transplantation exceeds six months at the majority of centers. The actual challenge in liver transplantation for alcoholic cirrhosis may well be the need for lifelong post-transplant follow-up rather than the patient's pre-transplant evaluation. A small number of recipients experience a relapse of alcoholism; these patients are at risk for organ damage and graft-related death. Post-transplant surveillance protocols should demonstrate alcohol relapse at an early stage, thus permitting the initiation of adequate treatment. Patients with alcoholic cirrhosis are at high risk of developing head and neck, esophageal, or lung cancer. The higher risk of malignancies should be considered in the routine assessment of patients suffering from alcoholic cirrhosis. Tumor surveillance protocols for liver transplant recipients, currently being developed, should become a part of standard care; these will improve survival by permitting diagnosis at an early stage. In conclusion, the key factor determining the outcome of transplantation for alcoholic cirrhosis is intensive lifelong medical and psychological care. Post-transplant surveillance might be much more important than pre-transplant selection.

Citing Articles

Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention.

Mehtani R, Rathi S J Clin Exp Hepatol. 2024; 14(6):101432.

PMID: 38975605 PMC: 11222954. DOI: 10.1016/j.jceh.2024.101432.


Workup and management of liver transplantation in alcohol-related liver disease.

Germani G, Degre D, Moreno C, Burra P United European Gastroenterol J. 2024; 12(2):203-209.

PMID: 38456339 PMC: 10954425. DOI: 10.1002/ueg2.12548.


Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.

Sedki M, Ahmed A, Goel A Transl Gastroenterol Hepatol. 2022; 7:26.

PMID: 35892052 PMC: 9257533. DOI: 10.21037/tgh-2020-13.


Sex Disparities in Outcome of Patients with Alcohol-Related Liver Cirrhosis within the Eurotransplant Network-A Competing Risk Analysis.

Listabarth S, Konig D, Berlakovich G, Munda P, Ferenci P, Kollmann D J Clin Med. 2022; 11(13).

PMID: 35806931 PMC: 9267400. DOI: 10.3390/jcm11133646.


Psychosocial characteristics of alcoholic and non-alcoholic liver disease recipient candidates in liver transplantation: a prospective observational study.

Shizuku M, Kimura H, Kamei H, Kishi S, Tokura T, Kurata N BMC Gastroenterol. 2021; 21(1):449.

PMID: 34844561 PMC: 8628411. DOI: 10.1186/s12876-021-02032-9.


References
1.
Lucey M . Liver transplantation in patients with alcoholic liver disease. Liver Transpl. 2011; 17(7):751-9. DOI: 10.1002/lt.22330. View

2.
DiMartini A, Crone C, Dew M . Alcohol and substance use in liver transplant patients. Clin Liver Dis. 2011; 15(4):727-51. DOI: 10.1016/j.cld.2011.08.002. View

3.
Berlakovich G, Soliman T, Freundorfer E, Windhager T, Bodingbauer M, Wamser P . Pretransplant screening of sobriety with carbohydrate-deficient transferrin in patients suffering from alcoholic cirrhosis. Transpl Int. 2004; 17(10):617-21. DOI: 10.1007/s00147-004-0765-9. View

4.
Finkenstedt A, Graziadei I, Oberaigner W, Hilbe W, Nachbaur K, Mark W . Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant. 2009; 9(10):2355-61. DOI: 10.1111/j.1600-6143.2009.02766.x. View

5.
Edwin D, Flynn L, Klein A, Thuluvath P . Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients. Hepatology. 1999; 30(6):1363-7. DOI: 10.1002/hep.510300605. View